Fingerprint
Dive into the research topics of 'Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically